Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Revelation Biosciences Inc
(NQ:
REVB
)
1.210
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revelation Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Nasdaq Down Over 200 Points; Williams-Sonoma Shares Tumble After Q2 Results
August 22, 2024
Via
Benzinga
Gold Down Over 1%; US Initial Jobless Claims Increase
August 22, 2024
Via
Benzinga
Dow Jumps 100 Points; BJ's Wholesale Earnings Top Estimates
August 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
August 22, 2024
Via
Benzinga
Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds
August 21, 2024
From
Revelation Biosciences Inc.
Via
Business Wire
US Stocks Higher; Target Posts Upbeat Earnings
August 21, 2024
Via
Benzinga
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
August 21, 2024
Via
Benzinga
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
August 14, 2024
Via
Benzinga
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q2 2024
August 09, 2024
REVB stock results show that Revelation Biosciences missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024
August 09, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Why Is Nano-Cap Revelation Biosciences Stock Skyrocketing On Monday?
June 24, 2024
Revelation Biosciences reveals positive safety and biomarker data from its Phase 1 study (RVL-HV02) of Gemini. The study met its primary endpoint and identified a maximum tolerated dose.
Via
Benzinga
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
June 24, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini
June 13, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
May 17, 2024
Via
Benzinga
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024
May 10, 2024
REVB stock results show that Revelation Biosciences missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
May 10, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 22, 2024
Via
Benzinga
REVB Stock Earnings: Revelation Biosciences Beats EPS for Q4 2023
March 22, 2024
REVB stock results show that Revelation Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023
March 22, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
March 14, 2024
Via
Benzinga
Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)
March 13, 2024
From
Revelation Biosciences Inc.
Via
Business Wire
Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference
March 12, 2024
From
Revelation Biosciences Inc.
Via
Business Wire
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
March 04, 2024
From
Revelation Biosciences Inc.
Via
Business Wire
Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
February 13, 2024
From
Revelation Biosciences Inc.
Via
Business Wire
Top 5 Health Care Stocks That Are Preparing To Pump In February
February 09, 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
BioMedNewsBreaks – Revelation Biosciences Inc. (NASDAQ: REVB) Secures ~$6.2M in Public Offering
February 08, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 07, 2024
Via
Benzinga
Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering
February 05, 2024
From
Revelation Biosciences Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
February 05, 2024
Via
Benzinga
Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 02, 2024
Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.